Tomislav Majić - Concepedia

Author

Tomislav Majić

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Majic, Tomislav, Majić, Tomislav, Majić, Tomislav 1975-, T. Majic, T. Majić, Tomislav Majic, Tomislav Majić, Tomislav Majić (8681397)

100

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Freie Universität Berlin St. Hedwig-Krankenhaus Humboldt-Universität zu Berlin Johannes Gutenberg University Mainz

About

Tomislav Majić is an author at Charité - Universitätsmedizin Berlin specializing in medicine, psychiatry, and nursing.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	259
2	Nursing	2	2	210
3	Education	1	1	163
4	Health Sciences	1	1	47
5	Public Health	1	1	29

Tomislav Majić

Publications

584

Citations

H-Index

Page 1

	Year	Citations
Animal-Assisted Therapy and Agitation and Depression in Nursing Home Residents with Dementia: A Matched Case–Control Trial Tomislav Majić, Hans Gutzmann, Andreas Heinz, American Journal of Geriatric Psychiatry NursingMatched Case–control TrialPsychiatryGeriatricsMedicine	2013	163
Schizophrenia risk polymorphisms in the <i>TCF4</i> gene interact with smoking in the modulation of auditory sensory gating Boris B. Quednow, Jürgen Brinkmeyer, Arian Mobascher, Proceedings of the National Academy of Sciences	2012	55
Correlates of agitation and depression in nursing home residents with dementia Tomislav Majić, Jan P. Pluta, T Mell, International Psychogeriatrics	2012	47
Agitation in Nursing Home Residents With Dementia (VIDEANT Trial): Effects of a Cluster-Randomized, Controlled, Guideline Implementation Trial Michael A. Rapp, T Mell, Tomislav Majić, Journal of the American Medical Directors Association NursingPsychiatryMental Health NursingGeriatricsDementia	2013	47
Apathy in Nursing Home Residents with Dementia: Results From A Cluster-Randomized Controlled Trial Yvonne Treusch, Tomislav Majić, Julie Page, European Psychiatry	2014	36
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design Lea J. Mertens, Michael Koslowski, Felix Betzler, Neuroscience Applied	2022	34
No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic Antonia Bendau, Leonard Viohl, Moritz Bruno Petzold, International Journal of Drug Policy Drug InteractionsLong CovidCovid-19 PandemicEarly Covid-19 PandemicPharmacotherapy	2022	29
COMT Val108/158Met genotype modulates human sensory gating Tomislav Majić, Johannes Rentzsch, Yehonala Gudlowski, NeuroImage Genetic DisorderComt Val108/158met GenotypeGeneticsGenetic EpidemiologyGenetic Factor	2010	26
Housing situation and healthcare for patients in a psychiatric centre in Berlin, Germany: a cross-sectional patient survey Stefanie Schreiter, Sascha Heidrich, Jamie Zulauf, BMJ Open	2019	25
Peripheral oxytocin is inversely correlated with cognitive, but not emotional empathy in schizophrenia Christiane Montag, Johanna Schöner, Lucas Guilherme Speck, PLoS ONE Affective NeuroscienceEmpathyPsychologySocial SciencesEmotional Response	2020	20

Page 1